TGFB1 and chronic lung disease: Environments with recurrent mechanical forces or increased stiffness such as those encountered in chronic lung diseases activate mechanotransduction signals to up-regulate fibroblast-dependent ECM activation by increasing fibroblast contractility, proliferation and migration towards fibrotic lesions through EMT and FMT (involving TGF-β1 signaling and increased α-SMA expression).